445 related articles for article (PubMed ID: 33562782)
1. Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Mangiaterra G; Carotti E; Vaiasicca S; Cedraro N; Citterio B; La Teana A; Biavasco F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562782
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
[No Abstract] [Full Text] [Related]
3. Role of Tobramycin in the Induction and Maintenance of Viable but Non-Culturable
Mangiaterra G; Cedraro N; Vaiasicca S; Citterio B; Galeazzi R; Laudadio E; Mobbili G; Minnelli C; Bizzaro D; Biavasco F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32664334
[TBL] [Abstract][Full Text] [Related]
4. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in
Mangiaterra G; Cedraro N; Vaiasicca S; Citterio B; Frangipani E; Biavasco F; Vignaroli C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511375
[TBL] [Abstract][Full Text] [Related]
6. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside antibiotics induce bacterial biofilm formation.
Hoffman LR; D'Argenio DA; MacCoss MJ; Zhang Z; Jones RA; Miller SI
Nature; 2005 Aug; 436(7054):1171-5. PubMed ID: 16121184
[TBL] [Abstract][Full Text] [Related]
8. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa variants obtained from veterinary clinical samples reveal a role for cyclic di-GMP in biofilm formation and colony morphology.
Brock MT; Fedderly GC; Borlee GI; Russell MM; Filipowska LK; Hyatt DR; Ferris RA; Borlee BR
Microbiology (Reading); 2017 Nov; 163(11):1613-1625. PubMed ID: 29034850
[TBL] [Abstract][Full Text] [Related]
10. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population.
Williamson KS; Richards LA; Perez-Osorio AC; Pitts B; McInnerney K; Stewart PS; Franklin MJ
J Bacteriol; 2012 Apr; 194(8):2062-73. PubMed ID: 22343293
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
[TBL] [Abstract][Full Text] [Related]
13. Real-time monitoring of
Žiemytė M; Carda-Diéguez M; Rodríguez-Díaz JC; Ventero MP; Mira A; Ferrer MD
Emerg Microbes Infect; 2021 Dec; 10(1):2062-2075. PubMed ID: 34663186
[TBL] [Abstract][Full Text] [Related]
14. Activity of Antibiotics against Pseudomonas aeruginosa in an
Diaz Iglesias Y; Van Bambeke F
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047
[No Abstract] [Full Text] [Related]
15. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
[TBL] [Abstract][Full Text] [Related]
16. Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms.
Maiden MM; Hunt AMA; Zachos MP; Gibson JA; Hurwitz ME; Mulks MH; Waters CM
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29661867
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
[TBL] [Abstract][Full Text] [Related]
18. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in surface sensing suggests a division of labor in
Armbruster CR; Lee CK; Parker-Gilham J; de Anda J; Xia A; Zhao K; Murakami K; Tseng BS; Hoffman LR; Jin F; Harwood CS; Wong GC; Parsek MR
Elife; 2019 Jun; 8():. PubMed ID: 31180327
[TBL] [Abstract][Full Text] [Related]
20. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
